Impact of depression on health utility value in cancer patients

Daisuke Fujisawa, Hironobu Inoguchi, Haruki Shimoda, Kazuhiro Yoshiuchi, Shinichiro Inoue, Asao Ogawa, Toru Okuyama, Tatsuo Akechi, Masaru Mimura, Ken Shimizu, Yosuke Uchitomi

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Objective: The quality-adjusted life year, which is usually calculated from the health utility value, is now a standard measurement used in political decision-making in health. Although depression is the leading cause of decrement in health utility in general population, impact of comorbid depression among cancer patients has not been studied sufficiently. Therefore, this study aimed to measure the impact of depression on cancer patients' health utility score, according to the severity of depression. Methods: Impact of depression severity (measured by the Patient Health Questionnaire) on health utility score (measured by the EuroQoL-5 scale) was evaluated in a sample of 328 Japanese cancer patients, controlling for performance status, symptom burden, and demographic variables. Results: The patients with depression had significantly lower health utility value than those without depression (mean decrement=0.14). Decrements in health utility of 0.13, 0.18, and 0.19 were observed for mild, moderate, and moderately severe to severe level of depression, respectively. The difference was significant between groups. Depression severity was a significant predictor for health utility (standardized coefficient beta=-0.25), which was comparable with physical symptom burden and performance status. Participants' age, gender, cancer stage, and comorbid illness were not significant. The model explained 37.9% of the variance. Conclusions: Even mild level of depression caused clinically meaningful decrement in health utility value in cancer patients, which was comparable with decrements due to major physical complications of cancer. Influence of depression should be carefully investigated when interpreting the quality-adjusted life year among cancer patients.

Original languageEnglish
JournalPsycho-Oncology
DOIs
Publication statusAccepted/In press - 2015

Fingerprint

Depression
Health
Neoplasms
Quality-Adjusted Life Years
Decision Making
Demography
Population

Keywords

  • Cancer
  • DALY
  • Depression
  • EQ-5D
  • Oncology
  • QALY

ASJC Scopus subject areas

  • Oncology
  • Psychiatry and Mental health
  • Experimental and Cognitive Psychology

Cite this

Fujisawa, D., Inoguchi, H., Shimoda, H., Yoshiuchi, K., Inoue, S., Ogawa, A., ... Uchitomi, Y. (Accepted/In press). Impact of depression on health utility value in cancer patients. Psycho-Oncology. https://doi.org/10.1002/pon.3945

Impact of depression on health utility value in cancer patients. / Fujisawa, Daisuke; Inoguchi, Hironobu; Shimoda, Haruki; Yoshiuchi, Kazuhiro; Inoue, Shinichiro; Ogawa, Asao; Okuyama, Toru; Akechi, Tatsuo; Mimura, Masaru; Shimizu, Ken; Uchitomi, Yosuke.

In: Psycho-Oncology, 2015.

Research output: Contribution to journalArticle

Fujisawa, D, Inoguchi, H, Shimoda, H, Yoshiuchi, K, Inoue, S, Ogawa, A, Okuyama, T, Akechi, T, Mimura, M, Shimizu, K & Uchitomi, Y 2015, 'Impact of depression on health utility value in cancer patients', Psycho-Oncology. https://doi.org/10.1002/pon.3945
Fujisawa, Daisuke ; Inoguchi, Hironobu ; Shimoda, Haruki ; Yoshiuchi, Kazuhiro ; Inoue, Shinichiro ; Ogawa, Asao ; Okuyama, Toru ; Akechi, Tatsuo ; Mimura, Masaru ; Shimizu, Ken ; Uchitomi, Yosuke. / Impact of depression on health utility value in cancer patients. In: Psycho-Oncology. 2015.
@article{e236920ce22c40f384b1ecbd136ea478,
title = "Impact of depression on health utility value in cancer patients",
abstract = "Objective: The quality-adjusted life year, which is usually calculated from the health utility value, is now a standard measurement used in political decision-making in health. Although depression is the leading cause of decrement in health utility in general population, impact of comorbid depression among cancer patients has not been studied sufficiently. Therefore, this study aimed to measure the impact of depression on cancer patients' health utility score, according to the severity of depression. Methods: Impact of depression severity (measured by the Patient Health Questionnaire) on health utility score (measured by the EuroQoL-5 scale) was evaluated in a sample of 328 Japanese cancer patients, controlling for performance status, symptom burden, and demographic variables. Results: The patients with depression had significantly lower health utility value than those without depression (mean decrement=0.14). Decrements in health utility of 0.13, 0.18, and 0.19 were observed for mild, moderate, and moderately severe to severe level of depression, respectively. The difference was significant between groups. Depression severity was a significant predictor for health utility (standardized coefficient beta=-0.25), which was comparable with physical symptom burden and performance status. Participants' age, gender, cancer stage, and comorbid illness were not significant. The model explained 37.9{\%} of the variance. Conclusions: Even mild level of depression caused clinically meaningful decrement in health utility value in cancer patients, which was comparable with decrements due to major physical complications of cancer. Influence of depression should be carefully investigated when interpreting the quality-adjusted life year among cancer patients.",
keywords = "Cancer, DALY, Depression, EQ-5D, Oncology, QALY",
author = "Daisuke Fujisawa and Hironobu Inoguchi and Haruki Shimoda and Kazuhiro Yoshiuchi and Shinichiro Inoue and Asao Ogawa and Toru Okuyama and Tatsuo Akechi and Masaru Mimura and Ken Shimizu and Yosuke Uchitomi",
year = "2015",
doi = "10.1002/pon.3945",
language = "English",
journal = "Psycho-Oncology",
issn = "1057-9249",
publisher = "John Wiley and Sons Ltd",

}

TY - JOUR

T1 - Impact of depression on health utility value in cancer patients

AU - Fujisawa, Daisuke

AU - Inoguchi, Hironobu

AU - Shimoda, Haruki

AU - Yoshiuchi, Kazuhiro

AU - Inoue, Shinichiro

AU - Ogawa, Asao

AU - Okuyama, Toru

AU - Akechi, Tatsuo

AU - Mimura, Masaru

AU - Shimizu, Ken

AU - Uchitomi, Yosuke

PY - 2015

Y1 - 2015

N2 - Objective: The quality-adjusted life year, which is usually calculated from the health utility value, is now a standard measurement used in political decision-making in health. Although depression is the leading cause of decrement in health utility in general population, impact of comorbid depression among cancer patients has not been studied sufficiently. Therefore, this study aimed to measure the impact of depression on cancer patients' health utility score, according to the severity of depression. Methods: Impact of depression severity (measured by the Patient Health Questionnaire) on health utility score (measured by the EuroQoL-5 scale) was evaluated in a sample of 328 Japanese cancer patients, controlling for performance status, symptom burden, and demographic variables. Results: The patients with depression had significantly lower health utility value than those without depression (mean decrement=0.14). Decrements in health utility of 0.13, 0.18, and 0.19 were observed for mild, moderate, and moderately severe to severe level of depression, respectively. The difference was significant between groups. Depression severity was a significant predictor for health utility (standardized coefficient beta=-0.25), which was comparable with physical symptom burden and performance status. Participants' age, gender, cancer stage, and comorbid illness were not significant. The model explained 37.9% of the variance. Conclusions: Even mild level of depression caused clinically meaningful decrement in health utility value in cancer patients, which was comparable with decrements due to major physical complications of cancer. Influence of depression should be carefully investigated when interpreting the quality-adjusted life year among cancer patients.

AB - Objective: The quality-adjusted life year, which is usually calculated from the health utility value, is now a standard measurement used in political decision-making in health. Although depression is the leading cause of decrement in health utility in general population, impact of comorbid depression among cancer patients has not been studied sufficiently. Therefore, this study aimed to measure the impact of depression on cancer patients' health utility score, according to the severity of depression. Methods: Impact of depression severity (measured by the Patient Health Questionnaire) on health utility score (measured by the EuroQoL-5 scale) was evaluated in a sample of 328 Japanese cancer patients, controlling for performance status, symptom burden, and demographic variables. Results: The patients with depression had significantly lower health utility value than those without depression (mean decrement=0.14). Decrements in health utility of 0.13, 0.18, and 0.19 were observed for mild, moderate, and moderately severe to severe level of depression, respectively. The difference was significant between groups. Depression severity was a significant predictor for health utility (standardized coefficient beta=-0.25), which was comparable with physical symptom burden and performance status. Participants' age, gender, cancer stage, and comorbid illness were not significant. The model explained 37.9% of the variance. Conclusions: Even mild level of depression caused clinically meaningful decrement in health utility value in cancer patients, which was comparable with decrements due to major physical complications of cancer. Influence of depression should be carefully investigated when interpreting the quality-adjusted life year among cancer patients.

KW - Cancer

KW - DALY

KW - Depression

KW - EQ-5D

KW - Oncology

KW - QALY

UR - http://www.scopus.com/inward/record.url?scp=84940056188&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940056188&partnerID=8YFLogxK

U2 - 10.1002/pon.3945

DO - 10.1002/pon.3945

M3 - Article

C2 - 26283141

AN - SCOPUS:84940056188

JO - Psycho-Oncology

JF - Psycho-Oncology

SN - 1057-9249

ER -